StockData
SCYNEXIS Inc logo

SCYNEXIS Inc (SCYX) stock

SCYXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 13/3074% below fair value
$2.60−0.21 (-7.62%)

Close on Nov 19, 2026Market cap $25.92MP/E –Yield –

Scynexis shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

Scynexis's shares outstanding was 12M at Jun 30, 2026. For fiscal 2025 it was 6M, up 2.9% from the year before. Over ten years it grew 45.0% a year on average. The highest annual figure on record is 6M in fiscal 2025.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 20256M+2.9%
FY2024Dec 31, 20246M+0.3%
FY2023Dec 31, 20236M+13.6%
FY2022Dec 31, 20225M+61.5%
FY2021Dec 31, 20213M+146.1%
FY2020Dec 31, 20201M+91.2%
FY2019Dec 31, 20191M+27.8%
FY2018Dec 31, 20181M+64.1%
FY2017Dec 31, 20170M+40.5%
FY2016Dec 31, 20160M+56.5%
FY2015Dec 31, 20150M+104.9%
FY2014Dec 31, 20140M+1669.1%
FY2013Dec 31, 20130M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 202612M+90.1%
Q1 FY2026Mar 31, 20266M+3.1%
Q4 FY2025Dec 31, 20256M+4.0%
Q3 FY2025Sep 30, 20256M+2.6%
Q2 FY2025Jun 30, 20256M+2.6%
Q1 FY2025Mar 31, 20256M+1.8%
Q4 FY2024Dec 31, 20246M+7.3%
Q3 FY2024Sep 30, 20246M+1.5%
Q2 FY2024Jun 30, 20246M-2.8%
Q1 FY2024Mar 31, 20246M+1.7%
Q4 FY2023Dec 31, 20236M-4.6%
Q3 FY2023Sep 30, 20236M+0.8%
Q2 FY2023Jun 30, 20236M+15.3%
Q1 FY2023Mar 31, 20236M+43.9%
Q4 FY2022Dec 31, 20226M+79.0%
Q3 FY2022Sep 30, 20226M+71.2%
Q2 FY2022Jun 30, 20225M+63.4%
Q1 FY2022Mar 31, 20224M+25.1%
Q4 FY2021Dec 31, 20213M+188.1%
Q3 FY2021Sep 30, 20213M+107.3%
Q2 FY2021Jun 30, 20213M+164.6%
Q1 FY2021Mar 31, 20213M+172.2%
Q4 FY2020Dec 31, 20201M+39.8%
Q3 FY2020Sep 30, 20202M+99.6%
Q2 FY2020Jun 30, 20201M+87.9%
Q1 FY2020Mar 31, 20201M+97.6%
Q4 FY2019Dec 31, 20191M+37.5%
Q3 FY2019Sep 30, 20191M+42.6%
Q2 FY2019Jun 30, 20191M+13.7%
Q1 FY2019Mar 31, 20191M+46.9%
Q4 FY2018Dec 31, 20181M+67.2%
Q3 FY2018Sep 30, 20181M+73.6%
Q2 FY2018Jun 30, 20181M+81.5%
Q1 FY2018Mar 31, 20180M+31.4%
Q4 FY2017Dec 31, 20170M+18.8%
Q3 FY2017Sep 30, 20170M+15.6%
Q2 FY2017Jun 30, 20170M–
Q1 FY2017Mar 31, 20170M–
Q4 FY2016Dec 31, 20160M–
Q3 FY2016Sep 30, 20160M–

More Scynexis figures

See a number that looks wrong?